参考文献

［1］何晓顺, 鞠卫强, 朱泽斌.“无缺血”器官移植时代的来临与展望[J]. 中华普通外科学文献(电子版),2018, 12(2): 73-75.

［2］ GROTH C G, BRENT L B, CALNE R Y, et al. Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles [J]. World J Surg, 2000, 24 (7):834-843.

［3］黄洁夫. 我国肝移植的现状与展望[J]. 中华器官移植杂志, 2000, 21(2): 4.

［4］黄洁夫, 陈规划, 陈秉学, 等. 体外静脉转流下进行的原位肝移植术[J]. 中山医科大学学报, 1994, 15(2):115-119.

［5］ HE X S, CHEN G D, ZHU Z B, et al. The first case of ischemia-free kidney transplantation in humans [J].Front Med (Lausanne), 2019, 6: 276.

［6］ HE X S, GUO Z Y, ZHAO Q, et al. The first case of ischemia-free organ transplantation in humans: a proof of concept [J]. Am J Transplant, 2018, 18 (3): 737-744.

［7］黄洁夫. 创建符合中国国情的器官捐献与移植体系[J]. 中华外科杂志, 2013, 51(1): 1-3.

［8］黄洁夫, 叶啟发. 建立中国模式的公民器官捐献体系, 为人民群众提供高质量的器官移植医疗服务[J].武汉大学学报(医学版), 2017, 38(6): 861-865.

［9］黄洁夫, 王海波, 郑树森, 等. 依法治国, 推进中国器官移植事业改革[J]. 中华医学杂志, 2014, 94(48):3793-3795.

［10］ ZHAO H L, ALAM A, SOO A P, et al. Ischemia-reperfusion injury reduces long term renal graft survival:mechanism and beyond [J]. EbioMedicine, 2018, 28: 31-42.

［11］ FERNANDEZ A R, SANCHEZ-TARJUELO R, CRAVEDI P, et al. Review: ischemia reperfusion injury-a translational perspective in organ transplantation [J]. Int J Mol Sci, 2020, 21 (22): 8549.

［12］ NIEUWENHUIJS-MOEKE G J, PISCHKE S E, BERGER S P, et al. Ischemia and reperfusion injury in kidney transplantation: relevant mechanisms in injury and repair [J]. J Clin Med, 2020, 9 (1): 253.

［13］ KAKO K, KATO M, MATSUOKA T, et al. Depression of membrane-bound Na+-K+-ATPase activity induced by free radicals and by ischemia of kidney [J]. Am J Physiol, 1988, 254 (2 Pt 1): C330-C337.

［14］ LI C Y, JACKSON R M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury [J]. Am J Physiol Cell Physiol, 2002, 282 (2): C227-C241.

［15］ KINROSS J, WARREN O, BASSON S, et al. Intestinal ischemia/reperfusion injury: defining the role of the gut microbiome [J]. Biomark Med, 2009, 3 (2): 175-192.

［16］ SALVADORI M, ROSSO G, BERTONI E. Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment [J]. World J Transplant, 2015, 5 (2): 52-67.

［17］ MARTIN J L, GRUSZCZYK A V, BEACH T E, et al. Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury [J]. Pediatr Nephrol, 2019, 34 (7): 1167-1174.

［18］ GRIENDLING K K, TOUYZ R M, ZWEIER J L, et al. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the american heart association [J]. Circ Res, 2016, 119 (5): e39-e75.

［19］ FORSTERMANN U, CLOSS E I, POLLOCK J S, et al. Nitric oxide synthase isozymes. Characterization,purification, molecular cloning, and functions [J]. Hypertension, 1994, 23 (6 Pt 2): 1121-1131.

［20］ RYTER S W, MORSE D, CHOI A M. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease [J]. Am J Respir Cell Mol Biol, 2007, 36 (2): 175-182.

［21］ ZHANG Q, RAOOF M, CHEN Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury [J]. Nature, 2010, 464 (7285): 104-107.

［22］ KANG J W, KIM S J, CHO H I, et al. DAMPs activating innate immune responses in sepsis [J]. Ageing Res Rev, 2015, 24 (Pt A): 54-65.

［23］ ANDREW J, MACDONALD P. Latest developments in heart transplantation: a review [J]. Clin Ther,2015, 37 (10): 2234-2241.

［24］ KURA B, SZEIFFOVA B B, KALOCAYOVA B, et al. Oxidative stress-responsive micrornas in heart injury [J]. Int J Mol Sci, 2020, 21 (1): 358.

［25］ BANAEI S, REZAGHOLIZADEH L. The role of hormones in renal disease and ischemia-reperfusion injury [J]. Iran J Basic Med Sci, 2019, 22 (5): 469-476.

［26］ LAUBACH V E, SHARMA A K. Mechanisms of lung ischemia-reperfusion injury [J]. Curr Opin Organ Transplant, 2016, 21 (3): 246-252.

［27］ SAKORAFAS G H, TSIOTOS G G, SARR M G. Ischemia/reperfusion-induced pancreatitis [J]. Dig Surg,2000, 17 (1): 3-14.

［28］ FUJIMOTO K, HOSOTANI R, WADA M, et al. Ischemia-reperfusion injury on the pancreas in rats: identification of acinar cell apoptosis [J]. J Surg Res, 1997, 71 (2): 127-136.

［29］ PATEL P M, CONNOLLY M R, COE T M, et al. Minimizing ischemia reperfusion injury in xenotransplantation [J]. Front Immunol, 2021, 12: 681504.

［30］ LE MOINE A, GOLDMAN M, ABRAMOWICZ D. Multiple pathways to allograft rejection [J]. Transplantation, 2002, 73 (9): 1373-1381.

［31］ RAMACHANDRAN V, KOLLI S S, STROWD L C. Review of graft-versus-host disease [J]. Dermatol Clin, 2019, 37 (4): 569-582.

［32］ STOLP J, ZAITSU M, WOOD K J. Immune tolerance and rejection in organ transplantation [J]. Methods Mol Biol, 2019, 1899: 159-180.

［33］ ALEGRE M L, FLORQUIN S, GOLDMAN M. Cellular mechanisms underlying acute graft rejection:time for reassessment [J]. Curr Opin Immunol, 2007, 19 (5): 563-568.

［34］ LIBBY P, POBER J S. Chronic rejection [J]. Immunity, 2001, 14 (4): 387-397.

［35］ COZZI E, COLPO A, DE SILVESTRO G. The mechanisms of rejection in solid organ transplantation [J].Transfus Apher Sci, 2017, 56 (4): 498-505.

［36］ VON ANDRIAN U H, MACKAY C R. T-cell function and migration. Two sides of the same coin [J]. N Engl J Med, 2000, 343 (14): 1020-1034.

［37］ ETRA J W, RAIMONDI G, BRANDACHER G. Mechanisms of rejection in vascular composite allotransplantation [J]. Curr Opin Organ Transplant, 2018, 23 (1): 28-33.

［38］ ADAMS A B, WILLIAMS M A, JONES T R, et al. Heterologous immunity provides a potent barrier to transplantation tolerance [J]. J Clin Invest, 2003, 111 (12): 1887-1895.

［39］王长希, 刘龙山. 抗体介导的排斥反应——任重道远, 攻坚克难[J]. 中华器官移植杂志, 2019, 40(8):449-451.

［40］ HALLORAN P F. Immunosuppressive drugs for kidney transplantation [J]. N Engl J Med, 2004, 351 (26):2715-2729.

［41］许晓光, 石炳毅, 蔡明. 移植排斥反应中若干问题的思考[J]. 医学与哲学, 2008, 29(6): 1-2; 8.

［42］ ANDOH T F, BURDMANN E A, BENNETT W M. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations [J]. Semin Nephrol, 1997, 17 (1): 34-45.

［43］ BRUGGENWIRTH I, VAN LEEUWEN O B, PORTE R J, et al. The emerging role of viability testing during liver machine perfusion [J]. Liver Transpl, 2022, 28 (5): 876-886.

［44］ JING L, YAO L, ZHAO M, et al. Organ preservation: from the past to the future [J]. Acta Pharmacol Sin,2018, 39 (5): 845-857.

［45］ LIU Q, NASSAR A, FARIAS K, et al. Comparing normothermic machine perfusion preservation with different perfusates on porcine livers from donors after circulatory death [J]. Am J Transplant, 2016, 16 (3):794-807.

［46］ BOETTCHER W, MERKLE F, WEITKEMPER H H. History of extracorporeal circulation: the conceptional and developmental period [J]. J Extra Corpor Technol, 2003, 35 (3): 172-183.

［47］ ŠUŠAK S, REDŽEK A, ROSIĆ M, et al. Development of cardiopulmonary bypass-a historical review [J].Srp Arh Celok Lek, 2016, 144 (11-12): 670-675.

［48］ BRETTSCHNEIDER L, DALOZE P M, HUGUET C, et al. Successful orthotopic transplantation of liver homografts after eight to twenty-five hours preservation [J]. Surg Forum, 1967, 18: 376-378.

［49］ MARECKI H, BOZORGZADEH A, PORTE R J, et al. Liver ex situ machine perfusion preservation: a review of the methodology and results of large animal studies and clinical trials [J]. Liver Transpl, 2017,23 (5): 679-695.

［50］ PLOEG R J, GOOSSENS D, MCANULTY J F, et al. Successful 72-hour cold storage of dog kidneys with UW solution [J]. Transplantation, 1988, 46 (2): 191-196.

［51］ MOERS C, SMITS J M, MAATHUIS M H, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation [J]. N Engl J Med, 2009, 360 (1): 7-19.

［52］ BRASILE L, STUBENITSKY B M, BOOSTER M H, et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion [J]. Transplantation, 2002, 73 (6): 897-901.

［53］ HOSGOOD S A, NICHOLSON M L. First in man renal transplantation after ex vivo normothermic perfusion [J]. Transplantation, 2011, 92 (7): 735-738.

［54］ DETELICH D, MARKMANN J F. The dawn of liver perfusion machines [J]. Curr Opin Organ Transplant,2018, 23 (2): 151-161.

［55］ WEISSENBACHER A, VRAKAS G, NASRALLA D, et al. The future of organ perfusion and re-conditioning [J]. Transpl Int, 2019, 32 (6): 586-597.

［56］ MARTINS P N, BUCHWALD J E, MERGENTAL H, et al. The role of normothermic machine perfusion in liver transplantation [J]. Int J Surg, 2020, 82S: 52-60.